By the end of the presentation, nurses will understand diabetes and insulin therapy. They will know the criteria for diagnosing diabetes, the different types of insulin and regimens, proper administration and storage techniques, and how to use insulin devices. The document discusses myths about insulin, outlines the types and classification of diabetes, and covers topics like symptoms, goals of treatment, insulin types and regimens, administration techniques, storage, and more. Nurses will gain knowledge on properly managing diabetes with insulin.
It includes information about Hybrid closed loop insulin delivery system-Artificial Pancreas.Its details and how insulin pump develops with the time.It also includes the information about companies which manufacturing pumps.Also includes info about diabetes mellitus.
Medication Insulin LisproDue July 2, 2017 Document APA FormatN.docxmccullaghjackelyn
Medication Insulin Lispro
Due July 2, 2017
Document APA Format
Note any additional references used
(See Attached information from the FDA-Food & Drug Administration)
Include information in the paper that is in
Bold
(see information noted from my initial research)
Pharmacokinetics
of Lispro
(Information to use) Used in management of Diabetes mellitus, types 1 and 2: Treatment of type 1 diabetes mellitus (insulin dependent, IDDM) and type 2 diabetes mellitus (noninsulin dependent, NIDDM) to improve glycemic control
Onset of action
Peak
Rapid acting: insulin lispro (Humalog)
0 to 15 minutes (Peak)
30 to 90 minutes (Onset of Action)
Half-life
Duration of action
Pharmacodynamics of Lispro insulin
Pharmacotherapeutics of Lispro
Include Drug-to-drug interactions,
Drug-to-food interactions
,
Drug-to-herb interactions
Routes and dosage ranges
For Children
For Adults
(Information to consider in writing paper)
Type 1 Diabetic : Note: Multiple daily doses or continuous subcutaneous infusions guided by blood glucose monitoring are the standard of diabetes care. Combinations of insulin formulations are commonly used. The daily doses presented below are expressed as the total units/kg/day of all insulin formulations combined.
Initial total insulin dose: 0.2 to 0.6 units/kg/day in divided doses. Conservative initial doses of 0.2 to 0.4 units/kg/day are often recommended to avoid the potential for hypoglycemia. A rapid-acting insulin may be the only insulin formulation used initially.
Usual maintenance range: 0.5 to 1 units/kg/day in divided doses. An estimate of anticipated needs may be based on body weight and/or activity factors as follows:
Nonobese: 0.4 to 0.6 units/kg/day
Obese: 0.8 to 1.2 units/kg/day
Adverse effects of Lispro
·
Cardiovascular: Peripheral edema
·
Central nervous system: Headache (type 1 diabetes: 30%; type 2 diabetes: 12%), pain (11% to 20%)
·
Endocrine & metabolic: Hypoglycemia, hypokalemia, weight gain
·
Gastrointestinal: Diarrhea (type 1 diabetes: 9%), nausea (type 1 diabetes: 6%)
·
·
Genitourinary: Urinary tract infection (type 1 diabetes: 6%)
·
·
Hypersensitivity: Hypersensitivity reaction
·
·
Immunologic: Antibody development
·
·
Infection: Infection (10% to 14%)
·
·
Local: Hypertrophy at injection site, injection site reaction, lipoatrophy at injection site
·
·
Neuromuscular & skeletal: Myalgia (type 1 diabetes: 7%; most likely secondary to excipient metacresol)
·
·
Respiratory: Flu-like symptoms (type 1 diabetes: 35%; type 2 diabetes: 6%), pharyngitis (type 1 diabetes: 33%; type 2 diabetes: 7%), rhinitis (type 1 diabetes: 25%; type 2 diabetes: 8%)
• Glycemic control: The most common adverse effect of insulin is hypoglycemia. The timing of hypoglycemia differs among various insulin formulations. Hypoglycemia may result from changes in meal pattern (eg, macronutrient content or timing of meals), changes in the level of physical activity, increased work or exercise without eating o ...
It includes information about Hybrid closed loop insulin delivery system-Artificial Pancreas.Its details and how insulin pump develops with the time.It also includes the information about companies which manufacturing pumps.Also includes info about diabetes mellitus.
Medication Insulin LisproDue July 2, 2017 Document APA FormatN.docxmccullaghjackelyn
Medication Insulin Lispro
Due July 2, 2017
Document APA Format
Note any additional references used
(See Attached information from the FDA-Food & Drug Administration)
Include information in the paper that is in
Bold
(see information noted from my initial research)
Pharmacokinetics
of Lispro
(Information to use) Used in management of Diabetes mellitus, types 1 and 2: Treatment of type 1 diabetes mellitus (insulin dependent, IDDM) and type 2 diabetes mellitus (noninsulin dependent, NIDDM) to improve glycemic control
Onset of action
Peak
Rapid acting: insulin lispro (Humalog)
0 to 15 minutes (Peak)
30 to 90 minutes (Onset of Action)
Half-life
Duration of action
Pharmacodynamics of Lispro insulin
Pharmacotherapeutics of Lispro
Include Drug-to-drug interactions,
Drug-to-food interactions
,
Drug-to-herb interactions
Routes and dosage ranges
For Children
For Adults
(Information to consider in writing paper)
Type 1 Diabetic : Note: Multiple daily doses or continuous subcutaneous infusions guided by blood glucose monitoring are the standard of diabetes care. Combinations of insulin formulations are commonly used. The daily doses presented below are expressed as the total units/kg/day of all insulin formulations combined.
Initial total insulin dose: 0.2 to 0.6 units/kg/day in divided doses. Conservative initial doses of 0.2 to 0.4 units/kg/day are often recommended to avoid the potential for hypoglycemia. A rapid-acting insulin may be the only insulin formulation used initially.
Usual maintenance range: 0.5 to 1 units/kg/day in divided doses. An estimate of anticipated needs may be based on body weight and/or activity factors as follows:
Nonobese: 0.4 to 0.6 units/kg/day
Obese: 0.8 to 1.2 units/kg/day
Adverse effects of Lispro
·
Cardiovascular: Peripheral edema
·
Central nervous system: Headache (type 1 diabetes: 30%; type 2 diabetes: 12%), pain (11% to 20%)
·
Endocrine & metabolic: Hypoglycemia, hypokalemia, weight gain
·
Gastrointestinal: Diarrhea (type 1 diabetes: 9%), nausea (type 1 diabetes: 6%)
·
·
Genitourinary: Urinary tract infection (type 1 diabetes: 6%)
·
·
Hypersensitivity: Hypersensitivity reaction
·
·
Immunologic: Antibody development
·
·
Infection: Infection (10% to 14%)
·
·
Local: Hypertrophy at injection site, injection site reaction, lipoatrophy at injection site
·
·
Neuromuscular & skeletal: Myalgia (type 1 diabetes: 7%; most likely secondary to excipient metacresol)
·
·
Respiratory: Flu-like symptoms (type 1 diabetes: 35%; type 2 diabetes: 6%), pharyngitis (type 1 diabetes: 33%; type 2 diabetes: 7%), rhinitis (type 1 diabetes: 25%; type 2 diabetes: 8%)
• Glycemic control: The most common adverse effect of insulin is hypoglycemia. The timing of hypoglycemia differs among various insulin formulations. Hypoglycemia may result from changes in meal pattern (eg, macronutrient content or timing of meals), changes in the level of physical activity, increased work or exercise without eating o ...
Insulin Initiation : When We should Start with Basal Insulin?mataharitimoer MT
Insulin Initiation : When We should Start with Basal Insulin?
Dr. Agus Taolin , SpPD, FINASIM | PAPDI CABANG BOGOR
Disampaikan pada acara PIT VI IDI Kota Bogor | 9 Nopember 2013
Diabetes Mellitus
Introduction
Pathophysiology
Types of Diabetes Mellitus
Type 1, 2 and
gestational diabetes
rescent research in Type 1 diabetes
Risk factors and causes
Complications short term and long term of diabetes
Management
Treatment with Insulin
Diabetic drugs
Healthy Diet
Exercises prescription
aerobic exercises,
resistance exercises and
flexibility
Diabetes is a chronic health condition that affects how the body converts food into energy. There are two main types of diabetes: type 1 and type 2. In type 1 diabetes, the body doesn't produce enough insulin, a hormone that regulates blood sugar levels. In type 2 diabetes, the body becomes resistant to insulin or doesn't produce enough insulin.
High blood sugar levels associated with diabetes can cause a range of health problems, including nerve damage, kidney disease, and heart disease. Managing diabetes involves monitoring blood sugar levels, taking medications, and making lifestyle changes such as eating a healthy diet and exercising regularly.
If you have diabetes, it's important to work closely with your healthcare provider to develop a treatment plan that meets your individual needs. This may include regular blood sugar testing, taking medications as prescribed, and making lifestyle changes to help manage your condition.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
More Related Content
Similar to nursing education program about insulin use
Insulin Initiation : When We should Start with Basal Insulin?mataharitimoer MT
Insulin Initiation : When We should Start with Basal Insulin?
Dr. Agus Taolin , SpPD, FINASIM | PAPDI CABANG BOGOR
Disampaikan pada acara PIT VI IDI Kota Bogor | 9 Nopember 2013
Diabetes Mellitus
Introduction
Pathophysiology
Types of Diabetes Mellitus
Type 1, 2 and
gestational diabetes
rescent research in Type 1 diabetes
Risk factors and causes
Complications short term and long term of diabetes
Management
Treatment with Insulin
Diabetic drugs
Healthy Diet
Exercises prescription
aerobic exercises,
resistance exercises and
flexibility
Diabetes is a chronic health condition that affects how the body converts food into energy. There are two main types of diabetes: type 1 and type 2. In type 1 diabetes, the body doesn't produce enough insulin, a hormone that regulates blood sugar levels. In type 2 diabetes, the body becomes resistant to insulin or doesn't produce enough insulin.
High blood sugar levels associated with diabetes can cause a range of health problems, including nerve damage, kidney disease, and heart disease. Managing diabetes involves monitoring blood sugar levels, taking medications, and making lifestyle changes such as eating a healthy diet and exercising regularly.
If you have diabetes, it's important to work closely with your healthcare provider to develop a treatment plan that meets your individual needs. This may include regular blood sugar testing, taking medications as prescribed, and making lifestyle changes to help manage your condition.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
2. By the end of the presentation
Nurses could be able to
Know about diabetes and its criteria for diagnosis.
Different types of insulin and its regimen.
Administration and storage.
Use insulin devices.
3. What would you prefer when you suffer from diabetes?
Oral drugs
Or
Insulin
????????????????????
4. Myth about Insulin
Is the last option ( where no any oral medication
works then only insulin is given.)
Once used should have to use life long so better not to
use rather I will have take 4-5 oral drugs.
Should have to refrigerate insulin so its a burden.
I feel hesitation when someone sees me injecting
insulin.
5. GOSPEL TRUTH ABOUT DIABETES
• Every
• 10 seconds 1 diabetics dies and
in that 10 seconds 2 new
diabetics are detected.
• 12 minutes one stroke
• 19 minutes one myocardial
infarction
• 19 minutes one major
amputation
• 60 minutes a new case of
dialysis
• 90 minutes a new case of
blindness
Liebl et al DMW
6. Diabetes
a chronic disease associated with abnormally high
levels of the sugar (glucose )in the blood.
Diabetes is due to one of two mechanisms:
Inadequate production of insulin (which is made by
the pancreas and lowers blood glucose), or
Inadequate sensitivity of cells to the action of insulin.
7. Etiological Classification of Diabetes Mellitus
I. Type 1 diabetes* - previously known as
juvenile diabetes
insulin-dependent diabetes mellitus (IDDM)
II. Type 2 diabetes* - previously known as
adult-onset diabetes
non-insulin-dependent diabetes mellitus (NIDDM)
III. Other specific types (includes Secondary Diabetes)
IV. Gestational diabetes mellitus (GDM)
*Patients with any form of diabetes may require insulin
treatment at some stage of their disease. Such use of insulin
does not, of itself, classify the patient.
American Diabetes Association: Clinical Practice Recommendations, updated
annually and published as a supplement to Diabetes Care and at
http://care.diabetesjournals.org/
9. Medical consequences of insulin deficiency
Hyperglycemic emergencies
Diabetic ketoacidosis (DKA)
• Chronic complications
– Neuropathy
– Microangiopathy
Retinopathy
Nephropathy
Foot ischemia
– Macroangiopathy - Atherosclerosis
Risk of cardiovascular death in type 1 diabetics vs. nondiabetics:
>5X higher in males, 7X higher in females
10. Poor glycemic control leads to long-
term complications…
Diabetic nephropathy
Proliferative
diabetic retinopathy
Sections through an artery
Atherosclerosis
Diabetic foot
11. Diagnostic Criteria
FPG=fasting plasma glucose; IFG=impaired fasting glucose;
IGT=impaired glucose tolerance; 2-hour PG=postprandial glucose (PPG) **HbA1c
based on the 2-hour PPG challenge with 75-gram glucose load. NGSP 2010
ADA. Diabetes Care. 2002;25(suppl 1):S5–S20; WHO 1999.
Normoglycemia Type 2 Diabetes
IFG
FPG (mg/dl) <110 110 and <126 126
(mmol/l) <6.1 6.1 and <7.0 7.0
IGT
2-h PG (mg/dl) <140 140 and <200 200
(mmol/l) <7.8 7.8 and <11.1 11.1
12. Goals of Glucose Management
Targets for glycemic control
American Diabetes Association. Diabetes Care. 2006;29(suppl 1):S4-S42. Implementation Conference for ACE
Outpatient Diabetes Mellitus Consensus Conference Recommendations: Position Statement at
http://www.aace.com/pub/pdf/guidelines/OutpatientImplementationPositionStatement.pdf. Accessed January
6, 2006. AACE Diabetes Guidelines – 2002 Update. Endocr Pract. 2002;8(suppl 1):40-82.
ADA AACE
A1c (%) <7* ≤6.5
Fasting (preprandial)
plasma glucose
90-130 mg/dL <110 mg/dL
Postprandial plasma
glucose
<180 mg/dL <140 mg/dL
*<6 for certain individuals
14. Discovery and characterization
In October 1920, Frederick Banting & Charles
Best: called isletin ( Insulin)
On January 11, 1922, Leonard Thompson, a
fourteen-year-old diabetic, was given the first
injection of insulin
15.
16. Ala
Tyr
Leu
Glu
Thr
Lys
Thr
Tyr Phe Phe Gly Arg
Glu
Gly
Cys
Val
Leu
Val
Leu
His
Ser
Gly
Cys
Leu
His
Gln
Asn
Val
Phe
B1
Asn Cys
Tyr
Asn
Glu
Leu
Gln
Tyr
Leu
Ser
Cys
Ile
Ser
Thr
Cys
Cys
Gln
Glu
Val
Ile
Gly A21
B30
Pro
Structure & Synthesis of Insulin
17. Insulin
Insulin is a naturally occurring hormone secreted by
the beta cells of the islets of Langerhans in the
pancreas in response to increased blood glucose
levels.1
Insulin regulates the blood glucose level and stores
excessive glucose for energy.2
1. Ehrlich RA. Patient care in radiography: With an introduction to medical imaging, 8th ed. Missouri:Elsevier Mosby; 2013. P. 470.
2. Mayo Clinic. Diabetes treatment: Using insulin to manage blood sugar [Internet]. 2015 [cited 2015 Oct 9]. Available from: www.mayoclinic.org/diseases-conditions/diabetes/in-
depth/diabetes-treatment/art-20044084
3. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2004;27(Suppl 1):s15–s35.
4. Kimball DM. Perceived knowledge of the registered nurse in managing hyperglycemia according to evidence-based practice in the acute care settings. Boca Raton: Florida
18. Pharmacologic treatment of type 2 diabetes [Internet]. 2015 [cited 2015 Oct 9]. Available from: www.columbia.edu/itc/hs/medical/clerkships/primcare/case/diabetes/diabetes01_07.html
Normal Insulin Secretion
The pancreas is constantly secreting basal insulin, which provides 50% of the body’s
requirement.
After a meal, the pancreatic beta-cells secrete bolus insulin in response to meals,
which supplies the body’s other 50% requirement.
19. Precautions for Storing Insulin Pens
1. GOSH NHS UK. Insulin: safe administration of [Internet]. 2015 [cited 2015 Sept 28]. Available from: http://www.gosh.nhs.uk/health-professionals/clinical-guidelines/insulin-safe-
administration.
2. Kalra S, et al. Forum for injection techniques, India: The first Indian recommendations for best practice in insulin injection technique. Indian J Endocr Metab 2012;16:876–85.
Should be refrigerated initially (2-8°C).1
Once the pen is in use there is no requirement for
refrigeration, but do not store above 30°C.1
Pens should never be stored with needles attached.2
If using mixed insulin, i.e., cloudy insulin, before using
the pen for the first time, the pen should be rolled
between the palms about 10 times.1
Thereafter, only turn the pen up and down prior to use
and do not shake.1
Analogues such as insulin Glulisine and insulin Glargine
do not need to be rolled.1
20. Different types of Insulin
Insulin Onset of action Peak of Action Duration ofAction
Short acting (RHI)
( Human insulin, Insuman)
30-60 min 2-4 h 6-8 h
Rapid acting analogue
Lispro ( Humalog) 15 min 1-2 h 2-5 h
Aspart ( Novorapid) 10-20 min 1-3 h 3-5 h
Glulisine ( Apidra ) 10-20 min 1-2 h 3-4 h
Intermediate Insulin
NPH ( Neutral protamine
hegedron )
1-3 h 5-7 h 13-16 h
LongActing Insulin analogue
Glargine ( Lantus) 1-2 h peakless 24 h
Premix Insulin
Insulin lispro 25/75 ( Humalog
Mix)
10 min 1-4 h 10-20 h
Insulin Aspart 30/70 ( Novo
Mix)
10 min 1-4 h 16-20 h
23. Once-daily Dosing Regimen
1. Diapedia. Insulin regimens [Internet]. 2015 [cited 2015 Oct 13 ]. Available from: http://www.diapedia.org/management/insulin-regimens
2. Levich BR. Diabetes management: optimizing roles for nurses in insulin initiation. J Multidiscip Healthc. 2011;4:15–24.
A single dose of insulin given each day.1,2
Long-acting insulin is given, mostly in the evening (for 24-hour
coverage). However, it can be given in the morning as well.1,2
24. Taken twice daily before breakfast and dinner to provide 24-hour
coverage
Also called biphasic because a fixed mixture of a short-acting insulin
and a long-acting insulin taken at each injection.
Twice-daily (Mixed-Insulin) Dosing Regimen
Diapedia. Insulin regimens [Internet]. 2015 [cited 2015 Oct 13]. Available from: http://www.diapedia.org/management/insulin-regimens
25. Basal–Bolus Dosing Regimen
1. NHS Lanarkshire. Basal bolus regimen insulin adjustment (multiple daily injection) [Internet]. 2013 [cited 2015 Oct 12]. Available from:
www.nhslanarkshire.org.uk/Services/Diabetes/Documents/Diabetes%20-%20Basal%20Bolus%20Regimen%20Insulin%20Adjustment.pdf
2. Dunning T. Care of people with diabetes: A manual of nursing practice, 4th ed. Sussex: John Wiley & Sons; 2013.
Basal insulin helps in maintaining the basic amount of insulin needed by the body at all
times by controlling the amount of glucose released. Basal insulin is long-acting insulin or
intermediate insulin as it needs to act over a relatively long period of time.1
Bolus Insulin helps in keeping blood glucose levels under control post-meal (mimics
pancreas role). Bolus insulin is either short-acting insulin or rapid-acting insulin as it
needs to act quickly.1
Basal-bolus regimen involves taking a long-acting insulin at bedtime to supply the basal
insulin requirements through periods of fasting and separate bolus injections of rapid- or
short-acting insulin are given before each meal to prevent blood glucose levels from
rising post-meals.2
26.
27. Insulin Administration
Primarily, there are primarily two routes of insulin administration:
1. Subcutaneous injection using:
Syringe
Insulin pen
Insulin pump
2. Intravenous infusion
30. Injection sites include the subcutaneous tissue of:1
the upper arm and the anterior and lateral portion
of the thigh
buttocks (slowest absorbing)
abdomen (fastest absorption) (except a 2-inch
radius around the navel).
Avoid the lateral portion of arm in small children with
little subcutaneous fat.2
Rotation of the injection site (recommended within
one area but at least 1 cm apart) is important to
prevent lipohypertrophy or lipoatrophy.1,2
Intramuscular injection is not recommended for
routine injections.1,2
1. American Diabetes Association. Insulin Administration. Diabetes Care. 2003; 26(Suppl 1):s121–4.
2. GOSH NHS UK. Insulin: safe administration of [Internet] . 2015 [cited 2015 Sept 28]. Available at: http://www.gosh.nhs.uk/health-
professionals/clinical-guidelines/insulin-safe-administration
Abdomen Upper arm
Anterior
thighs
Posterior
thighs Buttocks
Where to Inject the Insulin?
31. Insulin should be injected at 90° to the
skin using a two-finger ‘pinch-up’
technique.1
Do not aspirate for blood return when
giving insulin.2
Holding of the skin fold should be
maintained until the needle has been
withdrawn at the same angle from the
skin.1,2
For thin individuals or children, use short
needles or pinch the skin and inject at a
45° angle to avoid intramuscular
injection.3
Injection Procedure
Lifted skin fold No lifted Skin fold
32. Needle Length & Technique
Nurses should choose the correct needle length and injection
technique
33. Intravenous Insulin Infusion
Intravenous insulin is used in clinical settings to manage
hyperglycaemia.1
In the critical care setting, intravenous insulin infusion is
the most effective method for attaining glycaemic
targets.1
Indications for intravenous insulin infusion include:2
Critical care illness
Diabetic ketoacidosis
Myocardial infarction or cardiogenic shock
The post-operative period following heart surgery
34.
35. Precautions for Storing Insulin Vials
Nurses should take the following precautions for storing insulin vials:
Vials not in use should be refrigerated at 4-8°C, but not frozen.1,2
If refrigerated, then should be taken out and kept at room temperature
for at least 30 minutes before injecting.2
Avoid extreme temperatures (<2 or >3°C; e.g., direct sunlight, kitchen,
on top of electronics) and excess agitation to prevent loss of potency,
clumping, frosting, or precipitation.1,2
Keep insulin at room temperature (15-25°C) to limit local irritation at
the injection site, which may occur when cold insulin is used.1
Use an opened insulin vial within 1 month, after which there might be a
loss in potency.1
When insulin is used for the first time, ensure a label is used to note the
date and time of opening.3
If a refrigerator is not available, the vial can be labeled using water
proof stickers and placed in an water-filled earthen pitcher.2
36. Precautions for Storing Insulin Pens
Should be refrigerated initially (2-8°C).1
Once the pen is in use there is no requirement for
refrigeration, but do not store above 30°C.1
Pens should never be stored with needles attached.2
If using mixed insulin, i.e., cloudy insulin, before using
the pen for the first time, the pen should be rolled
between the palms about 10 times.1
Thereafter, only turn the pen up and down prior to use
and do not shake.1
Analogues such as insulin Glulisine and insulin Glargine
do not need to be rolled.1